Treatment  	Treatment  	 NN	O
of  	of  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis  	sclerosis  	 NN	O
and  	and  	 CC	O
neuromyelitis  	neuromyelitis  	 JJ	B-NP
optica  	optica  	 NN	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 FW	O
Paediatric  	Paediatric  	 FW	B-NP
multiple  	multiple  	 FW	I-NP
sclerosis  	sclerosis  	 FW	I-NP
( 	( 	 -LRB-	O
MS 	MS 	 NNP	B-NP
)  	)  	 -RRB-	O
accounts  	accounts  	 NNS	O
for  	for  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
5 	5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
MS  	MS  	 NNP	B-NP
cases 	cases 	 NNS	I-NP
.  	.  	 .	O
No  	No  	 DT	O
therapies  	therapies  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
formally  	formally  	 RB	O
approved  	approved  	 VBN	O
for  	for  	 IN	O
paediatric  	paediatric  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
published  	published  	 VBN	B-NP
experience  	experience  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
disease  	disease  	 NN	B-NP
modifying  	modifying  	 NN	I-NP
therapies  	therapies  	 NNS	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
with  	with  	 IN	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
Neuromyelitis  	Neuromyelitis  	 JJ	B-NP
optica  	optica  	 NNS	I-NP
( 	( 	 -LRB-	O
NMO 	NMO 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
an  	an  	 DT	O
autoimmune  	autoimmune  	 JJ	B-NP
inflammatory  	inflammatory  	 JJ	I-NP
disease  	disease  	 NN	I-NP
preferentially  	preferentially  	 VBZ	O
targeting  	targeting  	 VBG	O
the  	the  	 DT	O
optic  	optic  	 JJ	B-NP
nerves  	nerves  	 NNS	I-NP
and  	and  	 CC	O
spinal  	spinal  	 JJ	B-NP
cord 	cord 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
devastating  	devastating  	 JJ	O
disease  	disease  	 NN	O
usually  	usually  	 RB	O
requires  	requires  	 VBZ	O
preventive  	preventive  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
medications 	medications 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
are  	are  	 VBP	O
limited  	limited  	 JJ	O
studies  	studies  	 NNS	O
informing  	informing  	 VBG	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
medications  	medications  	 NN	O
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
NMO 	NMO 	 NNP	B-NP
.  	.  	 .	O
This  	This  	 DT	O
review  	review  	 NN	O
provides  	provides  	 VBZ	O
a  	a  	 DT	O
comprehensive  	comprehensive  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
published  	published  	 JJ	O
literature  	literature  	 NN	O
on  	on  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
interventions  	interventions  	 NNS	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
with  	with  	 IN	O
MS  	MS  	 NNP	B-NP
and  	and  	 CC	O
NMO 	NMO 	 NNP	B-NP
.  	.  	 .	O
